Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada.
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
JAMA Netw Open. 2023 Jul 3;6(7):e2321947. doi: 10.1001/jamanetworkopen.2023.21947.
Data suggest that the opioid crisis in North America has recently been reflected in opioid-related mortality among youths. Despite recommendation for its use, youths encounter barriers to accessing OAT, including stigma, burden of witnessed dosing, and lack of availability of youth-oriented services and prescribers comfortable treating this population.
To compare rates of opioid agonist treatment (OAT) and opioid-related mortality between youths aged 15 to 24 years and adults aged 25 to 44 years in Ontario, Canada, over time.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis of rates of OAT and opioid-related deaths between 2013 and 2021 used data obtained from the Ontario Drug Policy Research Network, Public Health Ontario, and Statistics Canada. Individuals included in the analysis were aged 15 to 44 years and residing in Ontario, the most populous province in Canada.
Youths aged 15 to 24 years compared with adults aged 25 to 44 years.
OAT (methadone, buprenorphine, and slow-release oral morphine) per 1000 population and opioid-related deaths per 100 000 population.
Between 2013 and 2021, 1021 youths aged 15 to 24 years died from opioid toxicity; 710 were male (69.5%). In the final year of the study period, 225 youths (146 male [64.9%]) died from opioid toxicity, and 2717 (1494 male [55.0%]) were dispensed OAT. Over the study period, the rate of opioid-related deaths among youths in Ontario increased 369.2% from 2.6 to 12.2 per 100 000 population (48 to 225 total deaths) and the rate of OAT use decreased 55.9% from 3.4 to 1.5 per 1000 (6236 to 2717 individuals). For adults aged 25 to 44 years, the rate of opioid-related deaths increased 371.8% from 7.8 to 36.8 per 100 000 (283 to 1502 deaths), and the rate of OAT increased 27.8% from 7.9 to 10.1 per 1000 population (28 667 to 41 200 individuals). Trends for youths and adults persisted across both sexes.
The findings of this study suggest that opioid-related deaths are increasing among youths while OAT use is paradoxically declining. The reasons for these observed trends require further investigation, including a consideration of changing trends in opioid use and opioid use disorder among youths, barriers to OAT, and opportunities to optimize care and reduce harms for youths who use substances.
有数据表明,北美阿片类药物危机最近已经反映在青少年的阿片类药物相关死亡率上。尽管建议使用,但青少年在获得 OAT 方面仍面临障碍,包括耻辱感、目睹给药的负担,以及缺乏面向青少年的服务和愿意治疗这一人群的医生。
比较加拿大安大略省 15 至 24 岁青少年和 25 至 44 岁成年人之间的阿片类药物激动剂治疗 (OAT) 和阿片类药物相关死亡率随时间的变化。
设计、设置和参与者:本横断面分析使用了安大略药物政策研究网络、安大略省公共卫生局和加拿大统计局获得的数据,比较了 2013 年至 2021 年期间 OAT 和阿片类相关死亡的发生率,研究对象为年龄在 15 至 44 岁、居住在安大略省的个人,安大略省是加拿大人口最多的省份。
15 至 24 岁的青少年与 25 至 44 岁的成年人相比。
每 1000 人中有多少人接受 OAT(美沙酮、丁丙诺啡和缓释口服吗啡)和每 100000 人中有多少人死于阿片类药物相关的死亡。
2013 年至 2021 年间,有 1021 名 15 至 24 岁的青少年死于阿片类药物中毒;其中 710 名为男性(69.5%)。在研究期间的最后一年,有 225 名青少年(146 名男性[64.9%])死于阿片类药物中毒,2717 名(1494 名男性[55.0%])接受了 OAT 治疗。在研究期间,安大略省青少年的阿片类相关死亡人数增加了 369.2%,从每 10 万人 2.6 例增加到 12.2 例(48 例至 225 例总死亡人数),OAT 的使用人数减少了 55.9%,从每 1000 人 3.4 例减少到 1.5 例(6236 例至 2717 例)。对于 25 至 44 岁的成年人,阿片类相关死亡人数增加了 371.8%,从每 10 万人 7.8 例增加到 36.8 例(283 例至 1502 例死亡),OAT 的使用人数增加了 27.8%,从每 1000 人 7.9 例增加到 10.1 例(28667 例至 41200 例)。青少年和成年人的趋势在两性中均持续存在。
这项研究的结果表明,青少年的阿片类相关死亡人数在增加,而 OAT 的使用却反常地减少。这些观察到的趋势的原因需要进一步调查,包括考虑青少年阿片类药物使用和阿片类药物使用障碍的变化趋势、OAT 的障碍以及为使用物质的青少年优化护理和减少伤害的机会。